Showing results (101-110 of 2,345) with videos related to
Sort By:
Pageof 235
The AAPS Journal|February 20, 2020
Biopharmaceutical Understanding of Excipient Variability on Drug Apparent Solubility Based on Drug Physicochemical Properties: Case Study-Hypromellose (HPMC)P Zarmpi, T Flanagan, E Meehan, et al.The AAPS Journal|February 21, 2020
Bayesian Individual Dynamic Predictions with Uncertainty of Longitudinal Biomarkers and Risks of Survival Events in a Joint Modelling Framework: a Comparison Between Stan, Monolix, and NONMEMFrançois Riglet, France Mentre, Christine Veyrat-Follet, et al.The AAPS Journal|January 16, 2020
Development of a Population Pharmacokinetics-Based in vitro-in vivo Correlation Model for Drugs with Site-Dependent Absorption: the Acyclovir Case StudySoyoung Shin, Tae Hwan Kim, Da Young Lee, et al.The AAPS Journal|January 17, 2020
An Agent-Based Systems Pharmacology Model of the Antibody-Drug Conjugate Kadcyla to Predict Efficacy of Different Dosing RegimensBruna Menezes, Cornelius Cilliers, Timothy Wessler, et al.The AAPS Journal|November 22, 2020
Keytruda and PD-L1: a Real-World Example of Co-development of a Drug with a Predictive BiomarkerKenneth EmancipatorThe AAPS Journal|November 17, 2020
Comparison of the ELISA and ECL Assay for Vedolizumab Anti-drug Antibodies: Assessing the Impact on Pharmacokinetics and Safety Outcomes of the Phase 3 GEMINI TrialsTimothy Wyant, Lili Yang, Maria RosarioThe AAPS Journal|October 25, 2020
Statistical Considerations in Assessing In Vivo Adhesion with Transdermal and Topical Delivery Systems for New Drug ApplicationsChao Wang, Caroline Strasinger, Meiyu Shen, et al.The AAPS Journal|November 13, 2020
Factors Affecting Successful Extrapolation of Ibuprofen Exposure from Adults to Pediatric Populations After Oral Administration of a Pediatric Aqueous SuspensionMarina Statelova, René Holm, Nikoletta Fotaki, et al.The AAPS Journal|March 19, 2020
Applying Beta Distribution in Analyzing Bounded Outcome Score DataChuanpu Hu, Honghui Zhou, Amarnath SharmaThe AAPS Journal|March 19, 2020
Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer PatientsSpinel Karas, Amy S Etheridge, Eleftheria Tsakalozou, et al.Pageof 235